Hormone therapy and ovarian cancer
Lancet
.
2015 Sep 12;386(9998):1037.
doi: 10.1016/S0140-6736(15)00137-3.
Authors
Frederick Naftolin
1
,
Jenna Friedenthal
2
,
Jennifer Blakemore
2
,
Lila Nachtigall
2
Affiliations
1
New York University School of Medicine, New York, NY 10016, USA. Electronic address: frederick.naftolin@nyumc.org.
2
New York University School of Medicine, New York, NY 10016, USA.
PMID:
26382990
DOI:
10.1016/S0140-6736(15)00137-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Estrogen Replacement Therapy / adverse effects*
Female
Humans
Ovarian Neoplasms / chemically induced*
Ovarian Neoplasms / epidemiology*